Alterations in intracellular calcium following infection of human endothelial cells with Trypanosoma cruzi.
Trypanosoma cruzi infection in cultured human umbilical vein endothelial cells increased basal cellular calcium levels from 55 to 110 nM, as monitored with the fluorescent probe, fura-2. It also influenced intracellular calcium such that consistently higher total levels were observed in response to bradykinin, angiotensin II and norepinephrine, as compared to similarly treated uninfected cells. However, bradykinin and angiotensin II-dependent increases in calcium, when considered as the absolute increment or fold elevation over basal, were significantly lower in infected endothelial cells. Infection also influenced changes in calcium levels due to agents that operate independently of plasma membrane receptors. In the presence of ionomycin, the magnitude and rate of rise of intracellular calcium were decreased; additionally the calcium peak was delayed and the subsequent decline slowed. Similar to the results with bradykinin and angiotensin II, infection decreased both the increment in and fold stimulation of intracellular calcium in response to ionomycin. In contrast, infection altered only the total calcium stimulated in response to oligomycin; neither the fold stimulation of, nor increment in intracellular calcium was affected. These results indicate that (1) infection by T. cruzi alters calcium homeostasis in endothelial cells under basal and stimulated conditions; (2) both receptor-dependent and receptor-independent mechanisms are affected by infection. The possible contribution of altered calcium homeostasis induced by T. cruzi in the pathogenesis of chagasic cardiomyopathy is considered.
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001920:Bradykinin / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism*; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000378:metabolism / Q000469:parasitology* / Q000648:ultrastructure; D004987:Ethers / Q000494:pharmacology; D006801:Humans; D015759:Ionomycin; D007476:Ionophores / Q000494:pharmacology; D008854:Microscopy, Electron; D009638:Norepinephrine / Q000494:pharmacology; D009840:Oligomycins / Q000494:pharmacology; D014349:Trypanosoma cruzi / Q000378:metabolism* / Q000648:ultrastructure; D014471:Umbilical Veins
D004987:Ethers; D007476:Ionophores; D009840:Oligomycins; D000804:Angiotensin II; D015759:Ionomycin; D001920:Bradykinin; D002118:Calcium; D009638:Norepinephrine